转移微质表现型:针对神经退行症中与疾病相关的微质
Athira Sasidharan1, Yogish Somayaji2, Ronald Fernandes3
1Department of Allied Health Sciences, Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangalore 575018, India.
ACS chemical neuroscience
|October 16, 2025
概括
与疾病相关的微质细胞 (DAMs) 在神经炎症和神经保护方面具有双重作用,影响神经退行性疾病,如阿尔茨海默氏症和帕金森氏症. 了解DAM对于开发有效治疗方法至关重要.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
背景情况:
- 神经退行性疾病涉及神经元损失和认知衰退,通常是由神经炎症驱动的.
- 微质细胞,大脑的免疫细胞,是神经炎症的核心,它们的调节失调会加剧神经元损伤.
研究的目的:
- 审查与疾病相关的微质 (DAMs) 在神经炎症和神经保护中的双重作用.
- 检查神经退行性疾病中DAMs独特的转录特征.
- 探索DAM功能对治疗开发的影响.
主要方法:
- 文献综述专注于神经退行症中微质的作用.
- 分析与疾病相关的微质细胞 (DAM) 功能,包括细胞化和细胞因子释放.
- 对特定的神经退行性疾病的检查:阿尔茨海默病 (AD),帕金森病 (PD) 和肌缩侧面硬化症 (ALS).
主要成果:
- 与疾病相关的微质细胞 (DAMs) 具有双重作用,有助于炎症和碎片清除.
- DAMs具有独特的转录特征,在神经退行性疾病中有所不同.
- 关键的激活通路,如TREM2-APOE通路,与DAMs的作用有关.
结论:
- 了解DAM复杂的双重功能对于有针对性的治疗策略至关重要.
- 对神经退行性疾病中的DAM相互作用的进一步研究可以指导未来的治疗开发.
- 向DAM为管理神经炎症和神经保护提供了一个有希望的途径.
相关概念视频
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Disorders of the Nervous Tissue
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


